454 related articles for article (PubMed ID: 2824821)
21. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
[TBL] [Abstract][Full Text] [Related]
22. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
23. Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells.
Wen LT; Tanaka A; Nonoyama M
J Virol; 1989 Aug; 63(8):3315-22. PubMed ID: 2545906
[TBL] [Abstract][Full Text] [Related]
24. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
25. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
Rowe M; Rowe DT; Gregory CD; Young LS; Farrell PJ; Rupani H; Rickinson AB
EMBO J; 1987 Sep; 6(9):2743-51. PubMed ID: 2824192
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
27. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
29. Molecular size variation of EBNA is determined by the EB viral genome.
Gergely L; Sternås L; Dillner J; Klein G
Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
[TBL] [Abstract][Full Text] [Related]
30. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
31. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
[TBL] [Abstract][Full Text] [Related]
32. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
Hu LF; Minarovits J; Cao SL; Contreras-Salazar B; Rymo L; Falk K; Klein G; Ernberg I
J Virol; 1991 Mar; 65(3):1558-67. PubMed ID: 1847471
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
34. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
35. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
36. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
Hewetson JF; Levine PH; Neubauer RH; Rabin H
Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
Rowe M; Rooney CM; Edwards CF; Lenoir GM; Rickinson AB
Int J Cancer; 1986 Mar; 37(3):367-73. PubMed ID: 3005176
[TBL] [Abstract][Full Text] [Related]
38. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
[TBL] [Abstract][Full Text] [Related]
39. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
[TBL] [Abstract][Full Text] [Related]
40. A simple method for the production of specific antiserum to the second nuclear antigen (EBNA-2) of Epstein-Barr virus (EBV).
Dewhurst S; Volsky DJ
J Immunol Methods; 1986 Mar; 87(2):283-7. PubMed ID: 3005420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
